Clinical Trial Update: Preoxygenation With Optiflow™ in Morbidly Obese Patients is Superior to Face Mask [NA]

View source ↗

Summary

A clinical trial comparing preoxygenation with Optiflow in morbidly obese patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity

Drugs mentioned

• Optiflow (nasal high-flow oxygen therapy device)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Obesity, Morbid | NA | Status: WITHDRAWN